Agf Investments Inc. Abb Vie Inc. Transaction History

Agf Investments Inc.

$10.6 Billion
Q3 2022

A detailed history of Agf Investments Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Agf Investments Inc. holds 1,025,539 shares of ABBV stock, worth $172 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

1,025,539

Previous 794,999 29.0%

Holding current value

$172 Million

Previous $122 Million 13.04%

% of portfolio

1.3%

Previous 1.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $30.9 Million - $35.5 Million	230,540 Added 29.0%	1,025,539 $138 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $3.75 Million - $4.77 Million	27,266 Added 3.55%	794,999 $122 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $8.71 Million - $10.8 Million	-66,001 Reduced 7.92%	767,733 $124 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $4.4 Million - $5.57 Million	-40,968 Reduced 4.68%	833,734 $113 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $22 Million - $24.9 Million	-206,300 Reduced 19.08%	874,702 $94.4 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $6.53 Million - $7.28 Million	-62,104 Reduced 5.43%	1,081,002 $122 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $12.7 Million - $14 Million	-124,207 Reduced 9.8%	1,143,106 $124 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $2.89 Million - $3.9 Million	-35,854 Reduced 2.75%	1,267,313 $136 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $213,400 - $250,461	2,484 Added 0.19%	1,303,167 $114 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $1.55 Million - $2.07 Million	-21,065 Reduced 1.59%	1,300,683 $128 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $613,717 - $930,471	9,515 Added 0.73%	1,321,748 $101 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $2.27 Million - $2.84 Million	-31,466 Reduced 2.34%	1,312,233 $116 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.6 Million - $1.93 Million	-25,449 Reduced 1.86%	1,343,699 $102 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $17.3 Million - $22.2 Million	-263,934 Reduced 16.16%	1,369,148 $99.6 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $1.86 Million - $2.19 Million	-24,139 Reduced 1.46%	1,633,082 $132 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $686,247 - $846,328	-8,815 Reduced 0.53%	1,657,221 $153 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $1.62 Million - $1.8 Million	-18,190 Reduced 1.08%	1,666,036 $158 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $15.2 Million - $17.9 Million	168,889 Added 11.15%	1,684,226 $156 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $2.76 Million - $3.7 Million	29,998 Added 2.02%	1,515,337 $143 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $1.84 Million - $2.02 Million	-20,554 Reduced 1.36%	1,485,339 $144 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $105 Million - $134 Million	1,505,893	1,505,893 $134 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.

Account

Agf Investments Inc. Abb Vie Inc. Transaction History